We studied through flow cytometry the expression of CD146 on different T cells, and B-cell ALL blasts trying to correlate its expression with different prognostic factors of B-cell ALL and treatment outcomes. The gene discussed is MCAM; the disease is acute lymphoblastic leukemia.